Bank of Montreal
AMRX icon

Bank of Montreal’s Amneal Pharmaceuticals AMRX Stock Holding History

Bank of Montreal’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132K Buy
+10,614
New +$143K ﹤0.01% 3059
2024
Q3 		– Sell
-36,078
Closed -$239K – 3840
2024
Q2 		$239K Buy
+36,078
New +$229K ﹤0.01% 2886
2023
Q2 		– Sell
-12,799
Closed -$24.6K – 3953
2023
Q1 		$24.6K Sell
12,799
-497
-4% -$990 ﹤0.01% 3492
2022
Q4 		$31K Buy
+13,296
New +$29.8K ﹤0.01% 3625
2021
Q2 		– Sell
-6,878
Closed -$42K – 3680
2021
Q1 		$42K Sell
6,878
-8,382
-55% -$46.5K ﹤0.01% 3778
2020
Q4 		$72K Buy
15,260
+10,678
+233% +$47.3K ﹤0.01% 3754
2020
Q3 		$19K Sell
4,582
-9,908
-68% -$42.4K ﹤0.01% 3852
2020
Q2 		$64K Buy
14,490
+10,588
+271% +$43.6K ﹤0.01% 3304
2020
Q1 		$12K Sell
3,902
-11,011
-74% -$46.6K ﹤0.01% 3413
2019
Q4 		$72K Buy
14,913
+6,697
+82% +$23.3K ﹤0.01% 3648
2019
Q3 		$24K Sell
8,216
-259
-3% -$904 ﹤0.01% 3982
2019
Q2 		$60K Buy
8,475
+3,954
+87% +$40.4K ﹤0.01% 3600
2019
Q1 		$64K Sell
4,521
-28,234
-86% -$373K ﹤0.01% 3251
2018
Q4 		$444K Buy
32,755
+627
+2% +$11.3K ﹤0.01% 2225
2018
Q3 		$713K Sell
32,128
-841
-3% -$17.7K ﹤0.01% 2157
2018
Q2 		$541K Buy
+32,969
New +$579K ﹤0.01% 2301

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bank of Montreal's AMRX Position: Q1 2026 in Review

Bank of Montreal opened a new position in Amneal Pharmaceuticals (AMRX) in Q1 2026: 10,614 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #3059 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in AMRX as recently as Q2 2024.

Bank of Montreal first reported a position in AMRX in Q2 2018 and has held it in 16 quarters since. The position peaked at $713K in Q3 2018. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Bank of Montreal held 10,614 shares of Amneal Pharmaceuticals worth $132K as of Q1 2026.
  • Amneal Pharmaceuticals was a new Bank of Montreal position in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3059 holding.
  • Bank of Montreal first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 16 quarters since.
  • Bank of Montreal's Amneal Pharmaceuticals position peaked at $713K in Q3 2018.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.